Stock listing
NASDAQ:FMI Foundation Medicine Inc Stock
Follow Foundation Medicine Inc into a list and get an email when it puts out news.
Last close · NASDAQ:FMI
$137.00 USD
Close on Jul 31, 2018 · No longer trades
- Lowest – highest close
- $13.71 – $137.00 USDSince Sep 25, 2013 · lowest Feb 9, 2016 · highest Jul 30, 2018
Delisted NASDAQ:FMI no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:FMI
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news
Foundation Medicine Inc on 6ix
- News releases
- 1 in the last 12 months · 1 in all · newest Nov 16, 2026 · oldest 2026
- Decks
- 6 decks · latest Jan 8, 2018
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| JP Morgan Healthcare Conference 2018 | Conference | 20 slides | Jan 8, 2018 |
| J.P. Morgan Healthcare Conference (January 2017) | Conference | 17 slides | Jan 9, 2017 |
| 2016 J.P. Morgan Annual Healthcare Conference | Conference | 22 slides | Jan 11, 2016 |
| Merger or Acquisition (January 2015) | Merger or acquisition | 49 slides | Jan 14, 2015 |
| Merger or Acquisition (January 2015) | Merger or acquisition | 20 slides | Jan 12, 2015 |
| Investor Presentation (January 2014) | Investor deck | 28 slides | Jan 13, 2014 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Sandra J. Horning Other companies: Revolution Medicines, Inc. (Director · Since at least Nov 9, 2023); Olema Pharmaceuticals, Inc. (Director · Since at least Nov 18, 2020); Moderna, Inc. (Director · Since at least Apr 29, 2020); Gilead Sciences, Inc. (Director · Since at least Jan 28, 2020); EQRx Inc (Director · Dec 17, 2021 – Nov 9, 2023 · Past) | Director · Apr 7, 2015 – Apr 7, 2015 · Past |
| Brook H Byers Other companies: CareDx, Inc. (Director · Jul 16, 2014 – Apr 1, 2016 · Past); Veracyte, Inc. (Director · Oct 29, 2013 – May 20, 2014 · Past); Pacific Biosciences of California, Inc. (Director · Oct 26, 2010 – May 17, 2016 · Past); Genomic Health Inc (Director · May 25, 2006 – Apr 1, 2011 · Past) | Director · Sep 24, 2013 – Apr 7, 2015 · Past |
| Evan Jones Other companies: Veracyte, Inc. (Board Member · Since at least Oct 29, 2013); CapForce Inc. (Director · May 4, 2015 – May 17, 2021 · Past); CAS Medical Systems Inc (Director · Jun 20, 2012 – Jun 24, 2013 · Past); Standard BioTools Inc. (Director · Dec 12, 2011 – Jul 31, 2017 · Past) | Director · Sep 24, 2013 – Jul 31, 2018 · Past |
| Jason Ryan Other companies: GeneDx Holdings Corp. (Director · Since at least Jul 22, 2021); Singular Genomics Systems Inc (Director · May 26, 2021 – Feb 21, 2025 · Past); Dianthus Therapeutics, Inc. (See Remarks · Jan 1, 2019 – Feb 10, 2020 · Past) | Chief Financial Officer · Sep 24, 2013 – Jul 31, 2018 · Past |
| Krishna Yeshwant Other companies: Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Verve Therapeutics Inc (Director · Since at least Jun 16, 2021); EQRx Inc (Director · Dec 17, 2021 – Nov 9, 2023 · Past) | Director · Jun 16, 2016 – Jul 31, 2018 · Past |
| Mark J Levin Other companies: Fulcrum Therapeutics, Inc. (Director · Jul 17, 2019 – Nov 10, 2021 · Past); Voyager Therapeutics, Inc. (Director · Nov 10, 2015 – Jun 3, 2021 · Past); Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – Mar 20, 2014 · Past) | Director · Sep 24, 2013 – May 12, 2014 · Past |
| David Daly Other companies: NeoGenomics, Inc. (Director · Nov 10, 2021 – Jun 10, 2022 · Past); Singular Genomics Systems Inc (President and Chief Operating · May 26, 2021 – Mar 4, 2022 · Past) | Chief Commercial Officer · Dec 2, 2014 – Aug 9, 2017 · Past |
| Michael Varney Other companies: Erasca, Inc. (Chair of R&D, SAB Member and Board Director · Since at least Jul 15, 2021); Pardes Biosciences Inc (Director · Dec 23, 2021 – Aug 31, 2023 · Past) | Director · Apr 7, 2015 – Apr 7, 2015 · Past |
| Michael J Doherty | Head of Product Development · Jun 20, 2017 – Jul 31, 2018 · Past |
Log in to ask 6ix AI your own questions about Foundation Medicine Inc.